sb 203580 has been researched along with indazoles in 5 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (indazoles) | Trials (indazoles) | Recent Studies (post-2010) (indazoles) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 5,609 | 550 | 3,265 |
| Protein | Taxonomy | sb 203580 (IC50) | indazoles (IC50) |
|---|---|---|---|
| Chain A, Cell Division Protein Kinase 2 | Homo sapiens (human) | 185 | |
| Chain A, CELL DIVISION PROTEIN KINASE 2 | Homo sapiens (human) | 185 | |
| Chain A, Cell Division Protein Kinase 2 | Homo sapiens (human) | 185 | |
| Chain A, CELL DIVISION PROTEIN KINASE 2 | Homo sapiens (human) | 185 | |
| Chain A, CELL DIVISION PROTEIN KINASE 2 | Homo sapiens (human) | 185 | |
| Chain A, CELL DIVISION PROTEIN KINASE 2 | Homo sapiens (human) | 185 | |
| Chain A, CELL DIVISION PROTEIN KINASE 2 | Homo sapiens (human) | 185 | |
| Chain A, CELL DIVISION PROTEIN KINASE 2 | Homo sapiens (human) | 185 | |
| Chain A, CELL DIVISION PROTEIN KINASE 2 | Homo sapiens (human) | 185 | |
| Chain A, CELL DIVISION PROTEIN KINASE 2 | Homo sapiens (human) | 185 | |
| Chain A, CELL DIVISION PROTEIN KINASE 2 | Homo sapiens (human) | 185 | |
| Chain A, CELL DIVISION PROTEIN KINASE 2 | Homo sapiens (human) | 185 | |
| Chain A, CELL DIVISION PROTEIN KINASE 2 | Homo sapiens (human) | 185 | |
| Chain A, Cell Division Protein Kinase 2 | Homo sapiens (human) | 185 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YM; Chiang, WC; Hsieh, BS; Lin, SL; Teng, CM; Tsai, TJ | 1 |
| Choi, I; Jeong, M; Kang, YH; Kim, MJ; Kim, MS; Kim, TD; Lee, SH; Myung, PK; Piao, ZH; Suh, HW; Yoon, SR; Yun, S | 1 |
| Bartsch, S; Klettner, A; Lassen, J; Roider, J; Westhues, D | 1 |
| Hsia, TC; Liu, CL; Yin, MC | 1 |
| Hamilton, BJ; Stan, RV; Tse, D | 1 |
5 other study(ies) available for sb 203580 and indazoles
| Article | Year |
|---|---|
YC-1-inhibited proliferation of rat mesangial cells through suppression of cyclin D1-independent of cGMP pathway and partially reversed by p38 MAPK inhibitor.
Topics: Animals; Blotting, Northern; Blotting, Western; Bromodeoxyuridine; CDC2-CDC28 Kinases; Cell Cycle Proteins; Cell Proliferation; Cells, Cultured; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP; Cyclin D1; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Enzyme Inhibitors; G1 Phase; Gene Expression; Glomerular Mesangium; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Guanylate Cyclase; Imidazoles; Indazoles; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Protein Kinase C; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Pyridines; Rats; RNA, Messenger; Signal Transduction; Solubility; Tumor Suppressor Proteins | 2005 |
YC-1 enhances natural killer cell differentiation from hematopoietic stem cells.
Topics: Blotting, Western; Cell Differentiation; Cell Line, Tumor; Cyclic GMP; Enzyme Activators; Enzyme Inhibitors; Fetal Blood; Flow Cytometry; Hematopoietic Stem Cells; Humans; Imidazoles; Indazoles; Killer Cells, Natural; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Receptors, Interleukin-15; Signal Transduction; STAT5 Transcription Factor | 2010 |
Regulation of constitutive vascular endothelial growth factor secretion in retinal pigment epithelium/choroid organ cultures: p38, nuclear factor κB, and the vascular endothelial growth factor receptor-2/phosphatidylinositol 3 kinase pathway.
Topics: Animals; Choroid; Chromones; Cinnamates; Cyclic S-Oxides; Imidazoles; Indazoles; Indoles; Maleimides; MAP Kinase Signaling System; Morpholines; NF-kappa B; Organ Culture Techniques; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Plicamycin; Pyridines; Retinal Pigment Epithelium; Signal Transduction; Sus scrofa; Transcription Factors; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2013 |
s-Methyl cysteine enhanced survival of nerve growth factor differentiated PC12 cells under hypoxic conditions.
Topics: Animals; bcl-2-Associated X Protein; Caspase 3; Caspase 8; Cell Differentiation; Cell Survival; Cysteine; DNA Fragmentation; Dose-Response Relationship, Drug; Glutathione Peroxidase; Glutathione Reductase; Hypoxia-Inducible Factor 1, alpha Subunit; Imidazoles; Indazoles; Membrane Potential, Mitochondrial; Nerve Growth Factor; Neuroprotective Agents; NF-kappa B; Nitric Oxide Synthase Type II; p38 Mitogen-Activated Protein Kinases; PC12 Cells; Pyridines; Pyrrolidines; Rats; Reactive Oxygen Species; Thiocarbamates; Tyrosine; Up-Regulation | 2014 |
Phorbol esters induce PLVAP expression via VEGF and additional secreted molecules in MEK1-dependent and p38, JNK and PI3K/Akt-independent manner.
Topics: Anthracenes; Autocrine Communication; Axitinib; Butadienes; Flavonoids; Gene Expression Regulation; Human Umbilical Vein Endothelial Cells; Humans; Imidazoles; Indazoles; MAP Kinase Kinase 1; MAP Kinase Kinase 4; Membrane Proteins; Nitriles; Phosphatidylinositol 3-Kinases; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyridines; Pyrimidines; RNA, Small Interfering; Signal Transduction; Sulfonamides; Tetradecanoylphorbol Acetate; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2019 |